{"id":40261,"date":"2025-06-16T12:47:29","date_gmt":"2025-06-16T12:47:29","guid":{"rendered":"https:\/\/www.evaluate.com\/thought-leadership\/biotech-oncology-forecasting-case-study\/"},"modified":"2025-10-22T12:19:49","modified_gmt":"2025-10-22T12:19:49","slug":"biotech-oncology-forecasting-case-study","status":"publish","type":"thought-leadership","link":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/","title":{"rendered":"Transforming Oncology Forecasting at a Clinical-Stage Biotech"},"content":{"rendered":"<p>When a fast-moving biotech with a broad oncology pipeline faced urgent forecasting challenges ahead of a pivotal Phase III launch, they turned to J+D Forecasting to overhaul their approach.<\/p>\n<p>What followed was a complete transformation &#8211; from fragmented, finance-led models to a scalable, best-practice forecasting framework built for strategic decision-making and long-term success.<br \/>\nIn this case study, you&#8217;ll learn how we enabled the company to:<\/p>\n<ul>\n<li>Adopt a robust patient-flow methodology using <a href=\"https:\/\/www.evaluate.com\/ja\/solutions\/pharmaceutical-forecasting-software\/oncology-forecasting-software\/\"><strong>Onco+<\/strong><\/a> to accelerate model development<\/li>\n<li>Upskill internal teams with hands-on support and tailored coaching<\/li>\n<li>Build a scalable, future-ready platform to prioritize assets and support commercialization<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Download the full case study<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>When a fast-moving biotech with a broad oncology pipeline faced urgent forecasting challenges ahead of a pivot [&hellip;]<\/p>\n","protected":false},"featured_media":36625,"menu_order":0,"template":"","meta":{"_acf_changed":false},"categories":[131],"tags":[152,91,10],"content-hub":[],"template-style":[],"class_list":["post-40261","thought-leadership","type-thought-leadership","status-publish","has-post-thumbnail","hentry","category-case-study","tag-case-study","tag-forecasting","tag-forecasts-market-landscape"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Transforming Oncology Forecasting at a Clinical-Stage Biotech | Evaluate<\/title>\n<meta name=\"description\" content=\"Discover how a clinical-stage biotech partnered with J+D Forecasting to transform its oncology forecasting\u2014accelerating Phase III launch readiness, building internal capability, and enabling strategic pipeline decisions with Onco+.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transforming Oncology Forecasting at a Clinical-Stage Biotech\" \/>\n<meta property=\"og:description\" content=\"Discover how a clinical-stage biotech partnered with J+D Forecasting to transform its oncology forecasting\u2014accelerating Phase III launch readiness, building internal capability, and enabling strategic pipeline decisions with Onco+.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Evaluate\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-22T12:19:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/06\/biotech-cs-fi-01.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2145\" \/>\n\t<meta property=\"og:image:height\" content=\"1425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@evaluatepharma\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/\",\"url\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/\",\"name\":\"Transforming Oncology Forecasting at a Clinical-Stage Biotech | Evaluate\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.evaluate.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/biotech-cs-fi-01.webp\",\"datePublished\":\"2025-06-16T12:47:29+00:00\",\"dateModified\":\"2025-10-22T12:19:49+00:00\",\"description\":\"Discover how a clinical-stage biotech partnered with J+D Forecasting to transform its oncology forecasting\u2014accelerating Phase III launch readiness, building internal capability, and enabling strategic pipeline decisions with Onco+.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.evaluate.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/biotech-cs-fi-01.webp\",\"contentUrl\":\"https:\\\/\\\/www.evaluate.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/biotech-cs-fi-01.webp\",\"width\":2145,\"height\":1425},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/thought-leadership\\\/biotech-oncology-forecasting-case-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transforming Oncology Forecasting at a Clinical-Stage Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/#website\",\"url\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/\",\"name\":\"Evaluate\",\"description\":\"Pharma commercial intelligence, news &amp; analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/#organization\",\"name\":\"Evaluate\",\"url\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.evaluate.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/EvaluateLogo2.svg\",\"contentUrl\":\"https:\\\/\\\/www.evaluate.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/EvaluateLogo2.svg\",\"width\":348,\"height\":145,\"caption\":\"Evaluate\"},\"image\":{\"@id\":\"https:\\\/\\\/www.evaluate.com\\\/ja\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/evaluatepharma\",\"https:\\\/\\\/uk.linkedin.com\\\/company\\\/evaluatepharma\\\/\"],\"description\":\"Evaluate provides trusted data, intelligence, and consulting services to help pharmaceutical and life sciences organisations make better decisions across research, development, and commercial strategy. Evaluate\u2019s solutions combine proprietary datasets, expert analysis, and forecasting to support portfolio strategy, competitive intelligence, and market understanding across the global pharma landscape. Evaluate is part of Norstella.\",\"email\":\"marketing@evaluate.com\",\"telephone\":\"+44 (0)20 7377 0800\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Transforming Oncology Forecasting at a Clinical-Stage Biotech | Evaluate","description":"Discover how a clinical-stage biotech partnered with J+D Forecasting to transform its oncology forecasting\u2014accelerating Phase III launch readiness, building internal capability, and enabling strategic pipeline decisions with Onco+.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/","og_locale":"ja_JP","og_type":"article","og_title":"Transforming Oncology Forecasting at a Clinical-Stage Biotech","og_description":"Discover how a clinical-stage biotech partnered with J+D Forecasting to transform its oncology forecasting\u2014accelerating Phase III launch readiness, building internal capability, and enabling strategic pipeline decisions with Onco+.","og_url":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/","og_site_name":"Evaluate","article_modified_time":"2025-10-22T12:19:49+00:00","og_image":[{"width":2145,"height":1425,"url":"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/06\/biotech-cs-fi-01.webp","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@evaluatepharma","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/","url":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/","name":"Transforming Oncology Forecasting at a Clinical-Stage Biotech | Evaluate","isPartOf":{"@id":"https:\/\/www.evaluate.com\/ja\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/#primaryimage"},"image":{"@id":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/#primaryimage"},"thumbnailUrl":"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/06\/biotech-cs-fi-01.webp","datePublished":"2025-06-16T12:47:29+00:00","dateModified":"2025-10-22T12:19:49+00:00","description":"Discover how a clinical-stage biotech partnered with J+D Forecasting to transform its oncology forecasting\u2014accelerating Phase III launch readiness, building internal capability, and enabling strategic pipeline decisions with Onco+.","breadcrumb":{"@id":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/#primaryimage","url":"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/06\/biotech-cs-fi-01.webp","contentUrl":"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/06\/biotech-cs-fi-01.webp","width":2145,"height":1425},{"@type":"BreadcrumbList","@id":"https:\/\/www.evaluate.com\/ja\/thought-leadership\/biotech-oncology-forecasting-case-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.evaluate.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Transforming Oncology Forecasting at a Clinical-Stage Biotech"}]},{"@type":"WebSite","@id":"https:\/\/www.evaluate.com\/ja\/#website","url":"https:\/\/www.evaluate.com\/ja\/","name":"Evaluate","description":"Pharma commercial intelligence, news &amp; analysis","publisher":{"@id":"https:\/\/www.evaluate.com\/ja\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.evaluate.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/www.evaluate.com\/ja\/#organization","name":"Evaluate","url":"https:\/\/www.evaluate.com\/ja\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.evaluate.com\/ja\/#\/schema\/logo\/image\/","url":"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/01\/EvaluateLogo2.svg","contentUrl":"https:\/\/www.evaluate.com\/wp-content\/uploads\/2025\/01\/EvaluateLogo2.svg","width":348,"height":145,"caption":"Evaluate"},"image":{"@id":"https:\/\/www.evaluate.com\/ja\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/evaluatepharma","https:\/\/uk.linkedin.com\/company\/evaluatepharma\/"],"description":"Evaluate provides trusted data, intelligence, and consulting services to help pharmaceutical and life sciences organisations make better decisions across research, development, and commercial strategy. Evaluate\u2019s solutions combine proprietary datasets, expert analysis, and forecasting to support portfolio strategy, competitive intelligence, and market understanding across the global pharma landscape. Evaluate is part of Norstella.","email":"marketing@evaluate.com","telephone":"+44 (0)20 7377 0800"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/thought-leadership\/40261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/thought-leadership"}],"about":[{"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/types\/thought-leadership"}],"version-history":[{"count":1,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/thought-leadership\/40261\/revisions"}],"predecessor-version":[{"id":42254,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/thought-leadership\/40261\/revisions\/42254"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/media\/36625"}],"wp:attachment":[{"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/media?parent=40261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/categories?post=40261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/tags?post=40261"},{"taxonomy":"content-hub","embeddable":true,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/content-hub?post=40261"},{"taxonomy":"template-style","embeddable":true,"href":"https:\/\/www.evaluate.com\/ja\/wp-json\/wp\/v2\/template-style?post=40261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}